Lexeo Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Lexeo Therapeutics Inc
TickerLXEO
CIK #0001907108
CUSIP52886X107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address345 Park Avenue South Floor 6, New York, NY 10010
Source [EDGAR]
CIK Filing 2011 - 2026
[0001907108] 10-K
[0001907108] 10-Q
[0001907108] 3
[0001907108] 4
[0001907108] 8-K
[0001907108] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Suvretta Capital Management LLC Lexeo Therapeutics Inc [2026-04-13] 0.0
Vanguard Group Inc Lexeo Therapeutics Inc [2026-01-30] 0.0
BlackRock Inc Lexeo Therapeutics Inc [2026-01-21] 0.0
Paradigm Biocapital Advisors LP Lexeo Therapeutics Inc [2025-11-20] 0.0
RA Capital Management LP Lexeo Therapeutics Inc [2025-10-27] 0.0
Balyasny Asset Management LP Lexeo Therapeutics Inc [2025-08-14] 0.0
Vestal Point Capital LP Lexeo Therapeutics Inc [2025-08-14] 0.0
Frazier Life Sciences Public Fund LP Lexeo Therapeutics Inc [2025-06-04] 0.0
Affinity Asset Advisors LLC Lexeo Therapeutics Inc [2025-06-04] 0.0
Integrated Core Strategies US LLC Lexeo Therapeutics Inc [2025-04-28] 0.0
Mizuho Financial Group Inc Lexeo Therapeutics Inc [2025-02-13] 0.0
BlackRock Inc Lexeo Therapeutics Inc [2025-02-04] 0.0
Adage Capital Management LP Lexeo Therapeutics Inc [2024-11-12] 7.86
Janus Henderson Group PLC Lexeo Therapeutics Inc [2024-02-14] 8.7
D1 Capital Partners LP Lexeo Therapeutics Inc [2024-02-14] 0.4
Lundbeckfond Invest A/S Lexeo Therapeutics Inc [2024-02-14] 6.9
Omega Fund VI LP Lexeo Therapeutics Inc [2024-02-14] 81948.1
Longitude Capital Partners IV LLC Lexeo Therapeutics Inc [2024-02-13] 81949.6
Eventide Asset Management LLC Lexeo Therapeutics Inc [2023-12-11] 11.93
Novo Holdings A/S Lexeo Therapeutics Inc [2023-11-24] 5.1
Citadel Advisors LLC Lexeo Therapeutics Inc [2023-11-17] 8.3
Form 3/4/5 Filer 2011 - 2026
Tamayo Louis Edward
Lexeo Therapeutics Inc
Bhalla Narinder Pal
Otero Jose Manuel
Townsend Richard Nolan
Cooperstone Brenda
Altschuler Steven
Cholmondeley Paula H
Agger Mette Kirstine
van Hauwermeiren Timothy
Tanguler Tolga
Diaz Reinaldo M
Sepp-Lorenzino Laura
Adler Eric
Robertson Jenny
See Tai Sandi
Rasbach Kyle
Lundbeckfond Invest A/S
Longitude Venture Partners IV LP
Enright Patrick G
Tammenoms Bakker Juliet
Longitude Capital Partners IV LLC
McCormac Paul
Nessi Claudio
Paster Anne-Mari
Omega Fund VI GP Manager Ltd
Stampacchia Otello
Omega Fund VI LP
Omega Fund VI GP LP
Davitian Bernard
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Otero Jose Manuel
Common Stock
2026-03-13 Grant 5,930 $2.64 15,655
Townsend Richard Nolan
Common Stock
2026-03-13 Grant 2,623 $2.64 6,925
Townsend Richard Nolan
Common Stock
2026-02-18 Sell 10,173 $6.38 64,904
Otero Jose Manuel
Common Stock
2026-02-18 Sell 3,016 $6.40 19,302
Bhalla Narinder Pal
Stock Option (right to buy) · derivative
2026-02-13 Grant 297,000 $0.00
Bhalla Narinder Pal
Common Stock
2026-02-13 Grant 49,500 $0.00
Tamayo Louis Edward
Common Stock
2026-02-04 Grant 44,665 $0.00
Townsend Richard Nolan
Common Stock
2026-02-04 Grant 161,665 $0.00
Otero Jose Manuel
Common Stock
2026-02-04 Grant 65,000 $0.00
Townsend Richard Nolan
Stock Option (right to buy) · derivative
2026-02-04 Grant 646,665 $0.00
Otero Jose Manuel
Stock Option (right to buy) · derivative
2026-02-04 Grant 260,000 $0.00
Tamayo Louis Edward
Stock Option (right to buy) · derivative
2026-02-04 Grant 226,665 $0.00
Robertson Jenny
Common Stock
2025-11-18 Sell 549 $9.27 5,089
Townsend Richard Nolan
Common Stock
2025-11-18 Sell 1,127 $9.27 10,447
Common Stock
2025-11-18 Sell 721 $9.27 6,684
Adler Eric
Common Stock
2025-11-18 Sell 615 $9.27 5,701
See Tai Sandi
Common Stock
2025-11-18 Sell 386 $9.27 3,578
Otero Jose Manuel
Common Stock
2025-10-17 Sell 2,091 $8.94 18,694
See Tai Sandi
Common Stock
2025-10-17 Sell 44 $9.56 421
See Tai Sandi
Common Stock
2025-10-17 Sell 3,844 $8.94 34,365
showing 20 of 136 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 140 79,966,118
2025-12-31 146 76,466,587
2025-09-30 109 49,331,663
2025-06-30 90 42,224,484
2025-03-31 89 28,028,183
2024-12-31 91 29,519,192
2024-09-30 70 29,833,583
2024-06-30 60 26,571,038
2024-03-31 55 23,153,734
2023-12-31 32 16,184,080
Form 13F Holdings
Firm Period DFND Voting Shares
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 265,697 265,697
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 159 12,745
Gamma Investing LLC [2026-06-30] DFND 247 247
Fortitude Family Office LLC [2026-06-30] SOLE 228 228
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 203
True Wealth Design LLC [2026-06-30] SOLE 0 197
Torren Management LLC [2026-06-30] SOLE 0 178
IFP Advisors LLC [2026-06-30] SOLE 172 172
Farther Finance Advisors LLC [2026-06-30] SOLE 0 159
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com